# EDGAR Filing Document

**Accession Number:** 0001508381
**File Stem:** 0001104659-23-005431
**Filing Date:** 2023-1
**Character Count:** 5968
**Document Hash:** 4c45bdb12f099615b62b34cd73098be0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-005431.hdr.sgml**: 20230120

**ACCESSION NUMBER**: 0001104659-23-005431

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20230119

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230120

**DATE AS OF CHANGE**: 20230120

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bionik Laboratories Corp.
- **CENTRAL INDEX KEY:** 0001508381
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **IRS NUMBER:** 271340346
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-54717
- **FILM NUMBER:** 23541438

**BUSINESS ADDRESS:**
- **STREET 1:** 80 COOLIDGE HILL ROAD
- **CITY:** WATERTOWN
- **STATE:** MA
- **ZIP:** 02472
- **BUSINESS PHONE:** 1-617-926-4800

**MAIL ADDRESS:**
- **STREET 1:** 80 COOLIDGE HILL ROAD
- **CITY:** WATERTOWN
- **STATE:** MA
- **ZIP:** 02472

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Drywave Technologies, Inc.
- **DATE OF NAME CHANGE:** 20130814

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Strategic Dental Management Corp.
- **DATE OF NAME CHANGE:** 20101220

?xml version="1.0" encoding="utf-8"?

---

| |
|:---|
| **UNITED STATES** |
| **SECURITIES AND EXCHANGE COMMISSION** |
| **WASHINGTON, DC 20549** |
| **FORM 8-K** |

---

---

| |
|:---|
| **CURRENT REPORT PURSUANT** |
| **TO SECTION 13 OR 15(D) OF THE** |
| **SECURITIES EXCHANGE ACT OF 1934** |
| Date of report (Date of earliest event reported): **January 19, 2023** |

---

BIONIK LABORATORIES CORP.

(Exact Name of Registrant as Specified in Its Charter)

<u>Delaware</u> <u>000-54717</u> <u>27-1340346</u> <br> (State or Other Jurisdiction of Incorporation or Organization) (Commission File Number) (IRS Employer Identification No.)

<u> 80 Coolidge Hill Road Watertown, MA</u> <u> 02472</u> <br> (Address of Principal Executive Offices) (Zip Code)

Registrant's Telephone Number, Including Area Code: (617) 926-4800

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see* General Instruction A.2. below):

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;◻ | &nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| &nbsp;&nbsp;&nbsp;◻ | &nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| &nbsp;&nbsp;&nbsp;◻ | &nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| &nbsp;&nbsp;&nbsp;◻ | &nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

---

---

| |
|:---|
| Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). |
| Emerging growth company ◻ |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻ |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp; **Title of each class** | &nbsp;&nbsp; **Trading Symbol** | &nbsp;&nbsp; **Name of each exchange on which registered** |
| &nbsp;&nbsp;Not applicable | &nbsp;&nbsp;Not applicable | &nbsp;&nbsp;Not applicable |

---

**Item 5.07 Submission of Matters to a Vote of Security Holders**

The Annual Meeting of Stockholders (the "Annual Meeting") of Bionik Laboratories Corp. (the "Company") was held on January 19, 2023. At the Annual Meeting, the stockholders of the Company voted on the following two proposals and cast their votes as described below. The proposals are described in more detail in the Company's Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on December 7, 2022.

Proposal 1: Election of the seven nominees listed below to serve on the Board of Directors of the Company until the next Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified:

---

| | | | |
|:---|:---|:---|:---|
| **Nominee** | **For** | **Withhold Authority** | **Broker Non-votes** |
| Andre Auberton-Herve | 3489934 | 7803 | 75827 |
| Remi Gaston-Dreyfus | 3490768 | 6969 | 75827 |
| Rich Russo Jr. | 3493270 | 4467 | 75827 |
| Joseph Martin | 3490768 | 6969 | 75827 |
| Charles Matine | 3490768 | 6969 | 75827 |
| Audrey Thevenon | 3490768 | 6969 | 75827 |
| Michal Prywata | 3490768 | 6969 | 75827 |

---

Proposal 2: To ratify MNP, LLP as the Company's independent public accountants for the year ending March 31, 2023.

---

| | | |
|:---|:---|:---|
| **For** | **Against** | **Abstain** |
| 3566547 | 5337 | 1680 |

---

**Item 9.01 Financial Statements and Exhibits.**

---

| | |
|:---|:---|
| **<u>Exhibit</u>** | **<u>Description</u>** |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: January 20, 2023

---

| | |
|:---|:---|
| **BIONIK LABORATORIES CORP.** | **BIONIK LABORATORIES CORP.** |
| By: | /s/ Rich Russo Jr. |
| Name: | Rich Russo Jr. |
| Title: | Chief Executive Officer |

---